Condensed Consolidated Statements of Operations (Unaudited) - USD ($) |
3 Months Ended | 9 Months Ended | ||
|---|---|---|---|---|
Sep. 30, 2023 |
Sep. 30, 2022 |
Sep. 30, 2023 |
Sep. 30, 2022 |
|
| REVENUE | $ 7,195,000 | $ 4,508,000 | $ 15,569,000 | $ 12,555,000 |
| COST OF REVENUE | 4,655,000 | 2,719,000 | 9,512,000 | 7,086,000 |
| GROSS PROFIT | 2,540,000 | 1,789,000 | 6,057,000 | 5,469,000 |
| Operating Expenses [Abstract] | ||||
| Selling, marketing and advertising | 3,161,000 | 2,958,000 | 8,767,000 | 8,693,000 |
| Engineering, technology and development | 2,066,000 | 3,827,000 | 7,268,000 | 12,607,000 |
| General and administrative | 2,271,000 | 3,249,000 | 7,094,000 | 9,118,000 |
| Contingent consideration | (462,000) | 1,836,000 | 546,000 | 1,836,000 |
| Loss on intangible asset disposal | 0 | 0 | 2,284,000 | 0 |
| Impairment of goodwill | 0 | 42,000,000 | 0 | 42,000,000 |
| Total operating expense | 7,036,000 | 53,870,000 | 25,959,000 | 74,254,000 |
| NET OPERATING LOSS | (4,496,000) | (52,081,000) | (19,902,000) | (68,785,000) |
| Nonoperating Income (Expense) [Abstract] | ||||
| Change in fair value of warrant liability | 1,512,000 | 0 | 2,552,000 | 0 |
| Interest expense | 0 | (514,000) | (43,000) | (493,000) |
| Other | 0 | (7,000) | 24,000 | (6,000) |
| Total other income (expense) | 1,512,000 | (521,000) | 2,533,000 | (499,000) |
| Loss before benefit from income taxes | (2,984,000) | (52,602,000) | (17,369,000) | (69,284,000) |
| Benefit from income taxes | 0 | 0 | 313,000 | 46,000 |
| NET LOSS | $ (2,984,000) | $ (52,602,000) | $ (17,056,000) | $ (69,238,000) |
| Earnings Per Share [Abstract] | ||||
| Basic and diluted net loss per common share (in dollars per share) | $ (1.01) | $ (28.14) | $ (7.44) | $ (37.37) |
| Weighted-average number of shares outstanding, basic and diluted (in shares) | 2,957,271 | 1,869,349 | 2,293,191 | 1,852,975 |
| X | ||||||||||
- Definition Payments for contingent consideration in operating expenses. No definition available.
|
| X | ||||||||||
- Definition The aggregate cost of goods produced and sold and services rendered during the reporting period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of expense (income) related to adjustment to fair value of warrant liability. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of gain (loss) on sale or disposal of intangible assets. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of loss from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of the cost of borrowed funds accounted for as interest expense. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business). Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense. No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The net result for the period of deducting operating expenses from operating revenues. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of income (expense) related to nonoperating activities, classified as other. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount, including tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value-added and excise. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The aggregate total amount of expenses directly related to the marketing or selling of products or services. No definition available.
|
| X | ||||||||||
- Definition This element represents the weighted average total number of shares issued throughout the period including the first (beginning balance outstanding) and last (ending balance outstanding) day of the period before considering any reductions (for instance, shares held in treasury) to arrive at the weighted average number of shares outstanding. Weighted average relates to the portion of time within a reporting period that common shares have been issued and outstanding to the total time in that period. Such concept is used in determining the weighted average number of shares outstanding for purposes of calculating earnings per share (basic). Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|